Benzinga - Fri, 19 Feb 2021 17:46:35 -0400
Benzinga - Thu, 18 Feb 2021 09:38:05 -0400
Benzinga - Thu, 18 Feb 2021 09:14:37 -0400
Benzinga - Thu, 18 Feb 2021 08:04:21 -0400
Benzinga - Wed, 17 Feb 2021 08:26:55 -0400
Benzinga - Fri, 12 Feb 2021 09:10:51 -0400
Benzinga - Thu, 11 Feb 2021 12:16:41 -0400
Benzinga - Thu, 11 Feb 2021 08:26:22 -0400
Benzinga - Wed, 10 Feb 2021 11:23:13 -0400
Benzinga - Wed, 10 Feb 2021 08:34:42 -0400
Benzinga - Tue, 09 Feb 2021 09:09:03 -0400
Benzinga - Mon, 08 Feb 2021 11:34:01 -0400
Benzinga - Mon, 08 Feb 2021 06:16:26 -0400
Benzinga - Fri, 29 Jan 2021 09:07:38 -0400
Benzinga - Wed, 27 Jan 2021 09:41:14 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Seelos Therapeutics Inc is engaged in the pharmaceutical industry. The company's pipeline products include SLS-002 which is intranasal racemic ketamine for patients with suicidality in post-traumatic stress disorder and depressive disorder; SLS-006 which is a small molecule, partial dopamine agonist for Parkinson's Disease; and SLS-005 is Trehalose, a protein stabilizer. Its other pipeline products include SLS-007, SLS-008, SLS-004, SLS-010, and SLS-012.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-06
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-16
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SEELSeelos Therapeutics-8.68%219.8M

Seelos Therapeutics Company Questions & Answers

Q

How do I buy Seelos Therapeutics (SEEL) stock?

A

You can purchase shares of Seelos Therapeutics (NASDAQ: SEEL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Seelos Therapeutics's (SEEL) main competitors?

A

Other companies in Seelos Therapeutics’s space includes: Xeris Pharmaceuticals (NASDAQ:XERS), Jaguar Health (NASDAQ:JAGX) and Aquestive Therapeutics (NASDAQ:AQST).

Q

What is the target price for Seelos Therapeutics?

A

The latest price target for Seelos Therapeutics (NASDAQ: SEEL) was reported by H.C. Wainwright on 2019-11-18. The analyst firm set a price target for 2.00 expecting SEEL to fall to within 12 months (a possible -34.43% downside). 0 analyst firms have reported ratings in the last year.

Q

How much is Seelos Therapeutics (SEEL) stock ?

A

The stock price for Seelos Therapeutics (NASDAQ: SEEL) is $3.05 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Seelos Therapeutics (SEEL) dividend?

A

There are no upcoming dividends for Seelos Therapeutics.

Q

When is Seelos Therapeutics (NASDAQ:SEEL) reporting earnings?

A
Seelos Therapeutics’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q

When is the upcoming split for SEEL?

A

There is no upcoming split for Seelos Therapeutics.